Is there a case for allocating to international small-cap equities?

Question

AcadiFi · Accepted Answer

International small-cap (MSCI EAFE Small Cap, MSCI ACWI ex-US Small Cap) offers distinct exposure from both domestic small-cap and international large-cap.

**Empirical case**:
- Long-term: international small-cap has returned ~9.5% annualized vs ~8.1% for international large-cap over 1999–2024.
- Lower correlation to US equities than international large-cap (~0.68 vs ~0.78).
- Higher idiosyncratic risk — more domestic-economy-sensitive and less globally integrated than international multinationals.
- Less analyst coverage — potential inefficiency premium for skilled managers.

**Why smaller international companies behave differently**:
1. Revenue more tied to local economy, not global demand.
2. Less hedged FX exposure at company level.
3. Higher exposure to domestic consumer, domestic services, domestic industrials.
4. Often under-researched — Berenberg and regional brokers cover but major US sell-side doesn't.

Worked example: Orinthia Global Fund's 2025 allocation: 40% US large, 20% US small, 25% international large, 5% international small, 10% emerging. Analyst Priya argues raising international small to 10% (from emerging). Backtest: blended volatility drops 30bps, Sharpe ratio rises from 0.48 to 0.52, reflecting the low correlation benefit.

**Risks and costs**: Higher trading costs, wider bid-ask spreads, less liquidity, currency risk not hedged at firm level, idiosyncratic governance risk in less-covered markets.

**Typical allocation**: 5–15% of international equity sleeve, implemented via dedicated passive (MSCI EAFE Small Cap IMI) or active managers with regional expertise.

The empirical diversification benefit is real but investors must tolerate higher tracking error and illiquidity.

Is there a case for allocating to international small-cap equities?

Master Level III with our CFA Course

Related Questions

Practice Questions